Similar articles

• Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma.

  Morton LM, Bernstein L, Wang SS, Hein DW, Rothman N, Colt JS, Davis S, Cerhan JR, Severson RK, Welch R, Hartge P, Zahm SH. Morton LM, et al. Carcinogenesis. 2007 Aug;28(8):1759-64. doi: 10.1093/carcin/bgm121. Epub 2007 May 23. Carcinogenesis. 2007. PMID: 17522066 Free PMC article.
• Reply: letter to the editor in response to Morton et al. (2007) Carcinogenesis, 28, 1759-1764.

  Bailey JE, Skare JA. Bailey JE, et al. Carcinogenesis. 2008 Sep;29(9):1851. doi: 10.1093/carcin/bgn022. Epub 2008 Jan 24. Carcinogenesis. 2008. PMID: 18218828 No abstract available.
• Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.

  Gibson TM, Smedby KE, Skibola CF, Hein DW, Slager SL, de Sanjosé S, Vajdic CM, Zhang Y, Chiu BC, Wang SS, Hjalgrim H, Nieters A, Bracci PM, Kricker A, Zheng T, Kolar C, Cerhan JR, Darabi H, Becker N, Conde L, Holford TR, Weisenburger DD, De Roos AJ, Butterbach K, Riby J, Cozen W, Benavente Y, Palmers C, Holly EA, Sampson JN, Rothman N, Armstrong BK, Morton LM. Gibson TM, et al. Cancer Causes Control. 2013 Jan;24(1):125-34. doi: 10.1007/s10552-012-0098-4. Epub 2012 Nov 18. Cancer Causes Control. 2013. PMID: 23160945 Free PMC article.
• Regulation of the activity of the human drug metabolizing enzyme arylamine N-acetyltransferase 1: role of genetic and non genetic factors.

  Rodrigues-Lima F, Dupret JM. Rodrigues-Lima F, et al. Curr Pharm Des. 2004;10(20):2519-24. doi: 10.2174/1381612043383845. Curr Pharm Des. 2004. PMID: 15320760 Review.
• Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.

  Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, Devanaboyina US, Nangju NA, Feng Y. Hein DW, et al. Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):29-42. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10667461 Review.